No single therapy is “best” for schizophrenia. The strongest outcomes come from combining antipsychotic medication with psychological therapy, and the specific therapy that helps most depends on which symptoms are causing the biggest problems. That said, cognitive behavioral therapy for psychosis (CBTp) has the broadest evidence base and is the most widely recommended psychological treatment by both the American Psychiatric Association and the UK’s National Institute for Health and Care Excellence (NICE).
A large study comparing medication alone to medication plus psychosocial therapy in early-stage schizophrenia found that combined treatment reduced the risk of relapse by 43% and the risk of dropping out of treatment by 38%. People in the combined group also showed greater improvements in social functioning, daily living skills, quality of life, and insight into their condition. A significantly higher proportion obtained employment or entered education. In short, medication manages core symptoms, and therapy builds the skills and understanding needed to live well.
Cognitive Behavioral Therapy for Psychosis
CBTp is the psychological therapy with the most research behind it for schizophrenia. It works by helping you examine and reframe the beliefs that surround psychotic experiences. If you hear voices, for example, CBTp doesn’t necessarily try to eliminate them. Instead, it helps you change your relationship with those experiences so they cause less distress and interfere less with daily life. The approach targets both the content of delusions and hallucinations and the emotional reactions they trigger.
Meta-analyses consistently show a small-to-moderate effect on positive symptoms (hallucinations and delusions), with effect sizes in the range of 0.31 to 0.37 compared to standard care alone. A broader meta-analysis of 34 studies found effects of 0.35 to 0.44 across positive symptoms, negative symptoms, mood, social anxiety, and overall functioning. Notably, the effectiveness of CBTp for treating delusions has increased over the past two decades as techniques have been refined.
A standard course of CBTp runs 12 to 20 one-on-one sessions over four to six months, following a structured treatment manual. Shorter versions of six to ten sessions in under four months also exist, though less evidence supports them. NICE recommends at least 16 planned sessions.
Family Intervention
Schizophrenia affects the whole household, and involving family members in treatment produces measurable benefits. A meta-analysis found that including relatives in the treatment process reduces relapse rates by 20%. Family interventions typically combine education about the condition with communication training and problem-solving strategies. The goal is to lower the emotional tension within the household that can trigger symptom flare-ups.
These programs also help family members recognize early warning signs of relapse and respond constructively rather than with criticism or over-involvement. Both the APA and NICE recommend family education and support as a core component of schizophrenia care, and it can begin as early as the first episode.
Social Skills Training
Many people with schizophrenia struggle with the social side of life: reading facial expressions, holding conversations, being assertive, and managing everyday tasks like keeping an organized home. Social skills training (SST) directly addresses these challenges through modeling, role-playing, and practice in real-world settings.
Research shows large improvements in actual skill acquisition and moderate improvements in negative symptoms, which are the harder-to-treat features of schizophrenia like social withdrawal, flat emotional expression, and reduced motivation. A meta-analysis of 27 clinical trials found that SST produced significant medium-sized effects on negative symptoms compared to both standard care and other active treatments, with benefits lasting up to a year after treatment ended.
One reason SST works on negative symptoms, even though it wasn’t originally designed for them, is that it incorporates goal-setting and behavioral activation. Breaking long-term recovery goals into small, achievable daily steps creates regular reinforcing experiences. Deficits in social motivation alone account for over 20% of the variation in social outcomes among people with schizophrenia, so building momentum through small successes can have outsized effects on overall functioning.
Cognitive Remediation
Schizophrenia often impairs thinking skills like memory, attention, and the ability to plan and organize. Cognitive remediation uses structured exercises, often computer-based, to strengthen these mental abilities. Think of it as targeted practice for the brain’s core processing functions.
There are two main forms. Neurocognitive remediation focuses on memory, attention, and processing speed. Social cognitive remediation targets the ability to read emotions, understand social cues, and interpret other people’s intentions. A recent multicenter study found that each type improves the specific domain it targets: social cognitive remediation produced a large improvement in recognizing facial emotions, while neurocognitive remediation improved verbal learning and memory. The takeaway is that the type of cognitive remediation should match the specific difficulties a person is experiencing.
Coordinated Specialty Care for First Episodes
If you or someone you know is experiencing psychosis for the first time, the most effective approach is a coordinated specialty care (CSC) program. Rather than offering a single therapy, CSC wraps five core services into one team-based program: cognitive or behavioral psychotherapy, medication management, family education and support, case management, and supported employment or education services. The team uses small caseloads, regular meetings, and assertive outreach to keep people engaged.
The National Institute of Mental Health recommends CSC as the standard approach for first-episode psychosis, and the APA gives it a strong recommendation. Compared to standard community treatment, people in CSC programs experience fewer hospitalizations, better vocational engagement, and greater improvements in quality of life and depressive symptoms. Cost-effectiveness analyses suggest these programs deliver better outcomes without significantly higher total treatment costs, largely because they prevent expensive emergency room visits and inpatient stays.
Assertive Community Treatment for Severe Cases
For people with more severe or persistent schizophrenia who have difficulty maintaining stable housing or staying connected to care, Assertive Community Treatment (ACT) brings the treatment team to the person rather than expecting them to show up at a clinic. A multidisciplinary team visits clients in their homes and communities, helping with everything from organizing daily routines to managing medications to solving practical problems in real time.
Research shows that ACT participants have fewer psychiatric hospitalizations, reduced symptom severity, more stable housing, and improved quality of life. The key advantage is that clinicians can address problems as they actually occur, in the settings where they occur, rather than discussing them abstractly in an office.
How to Think About Choosing a Therapy
The best therapy depends on what’s causing the most difficulty right now. If hallucinations and delusions are the primary burden, CBTp has the strongest evidence. If social withdrawal and lack of motivation are the bigger obstacles, social skills training has targeted benefits. If thinking and memory problems are interfering with work or school, cognitive remediation addresses those directly. If family conflict is contributing to relapses, family intervention can cut relapse rates significantly.
In practice, the most effective treatment plans combine several of these approaches alongside medication. The APA recommends a comprehensive, person-centered plan that integrates both pharmacological and nonpharmacological treatments. Recovery from schizophrenia is not about finding one perfect therapy. It is about assembling the right combination of supports for a person’s specific symptoms, goals, and stage of illness.

